Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients.
Clinical trial NCT02315768 · COMPLETED
Trial details
- NCT number
- NCT02315768
- Sponsor
- University of California, San Diego
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-26
- Primary completion
- 2022-04-18
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.